
Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach
Keywords: DEHP; MEHP; Pharmacokinetics; PBPK; Human health risk assessment; IVIVE; Endocrine disruptors; Human biomonitoring;